Get the Stockscreener App
7.12
6.91%
0.46
Adial Pharmaceuticals Inc Stock (ADIL) Forecast
The Adial Pharmaceuticals Inc (ADIL) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $37.48, representing a +426.42% increase from the current price of $7.12. The highest analyst price target is $51.42, and the lowest is $23.55.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month ADIL Price Target
Average 49.86
(+600.26% Upside)
Is Adial Pharmaceuticals Inc (ADIL) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 79.07 | Sell |
| STOCH(9,6) | 84.52 | Sell |
| STOCHRSI(14) | 66.38 | Neutral |
| MACD(12,26) | 0.7414 | Buy |
| ADX(14) | 52.80 | Buy |
| William %R | -6.7826 | Sell |
| CCI(14) | 104.77 | Buy |
Buy: 3
Sell: 3
Neutral: 1
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
4.951
Buy
|
5.1362
Buy
|
| MA20 |
4.266
Buy
|
4.4951
Buy
|
| MA50 |
3.3488
Buy
|
3.6079
Buy
|
| MA100 |
2.5732
Buy
|
3.3449
Buy
|
| MA200 |
3.8199
Buy
|
4.5859
Buy
|
Buy: 10
Sell: 0
Neutral: 0
Summary: Buy
According to our latest analysis, ADIL could be considered a Strong Buy, with 17 technical analysis indicators signaling 13 Buy signals, 3 signaling Sell signals and 1 Neutral signals. This might be a good time to open fresh positions on ADIL, as trading bullish markets is always a lot easier
- RSI (Relative Strength Index): The RSI(14) value of 79.07 indicates that ADIL is overbought. This suggests that ADIL price has experienced a significant increase over a specified lookback period, potentially leading to a correction.
- STOCH (Stochastic Oscillator): The STOCH value of 84.52 indicates that ADIL is oversold. This means that ADIL price is at or near the highest level over a specified lookback period.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 66.38 indicates that ADIL is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 52.8 suggests an extremely strong trend in the market. Such high values are relatively rare and indicate a very robust directional movement.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of 104.77 indicates that ADIL is overbought. This means that the price has moved significantly higher than its average, indicating a potential selling opportunity.
Long-term ADIL price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Adial Pharmaceuticals Inc financial reports and earnings history, Adial Pharmaceuticals Inc (ADIL) stock could reach $58.46 by 2030, $33.48 by 2040 and $81.67 by 2050. See the projected annual prices until 2050 of the Adial Pharmaceuticals Inc stock below:
- Adial Pharmaceuticals Inc (ADIL) is expected to reach an average price of $11.92 in 2035, with a high prediction of $13.37 and a low estimate of $12.03. This indicates an $67.42% rise from the last recorded price of $7.12.
- Adial Pharmaceuticals Inc (ADIL) stock is projected to chart a bullish course in 2040, with an average price target of $31.80, representing an $346.65% surge from its current level. The forecast ranges from a conservative $32.72 to a sky-high $33.48.
- Our analysts predict Adial Pharmaceuticals Inc (ADIL) to jump 884.94% by 2045, soaring from $69.95 to an average price of $70.13, potentially reaching $69.09. While $69.95 is the low estimate, the potential upside is significant.
- Adial Pharmaceuticals Inc (ADIL) stock is expected to climb by 2050, reaching an average of $82.97, a $1,065% jump from its current level. However, a wide range of estimates exists, with high and low targets of $81.67 and $83.07, respectively, highlighting the market's uncertainty.
Adial Pharmaceuticals Inc Stock (ADIL) Year by Year Forecast
Adial Pharmaceuticals Inc Stock (ADIL) Price Forecast for 2026
The predicted value for Adial Pharmaceuticals Inc (ADIL) in 2026 is set at an average of $48.08. Estimates vary from a peak of $95.50 to a trough of $0.6465, indicating an +575.21% surge from the present price of $7.12.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| October, 2026 | $35.49 | $23.55 | $51.42 | +398.40% |
| November, 2026 | $70.24 | $33.68 | $80.81 | +886.58% |
| December, 2026 | $75.69 | $66.06 | $95.50 | +963.11% |
Adial Pharmaceuticals Inc Stock (ADIL) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Adial Pharmaceuticals Inc (ADIL) is $44.45, with a high forecast of $85.70 and a low forecast of $3.2016. This indicates an +524.33% increase from the last price of $7.12.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $56.20 | $56.20 | $85.70 | +689.36% |
| February, 2027 | $45.71 | $43.33 | $65.14 | +542.01% |
| March, 2027 | $36.91 | $31.16 | $48.90 | +418.40% |
| April, 2027 | $37.42 | $31.73 | $47.60 | +425.55% |
| May, 2027 | $32.68 | $23.93 | $37.86 | +358.96% |
| June, 2027 | $20.63 | $17.88 | $38.37 | +189.70% |
| July, 2027 | $24.64 | $18.07 | $29.39 | +246.01% |
| August, 2027 | $16.14 | $14.02 | $31.39 | +126.75% |
| September, 2027 | $7.8432 | $4.2137 | $16.83 | +10.16% |
| October, 2027 | $9.3522 | $6.3522 | $16.41 | +31.35% |
| November, 2027 | $9.3611 | $3.2016 | $11.54 | +31.48% |
| December, 2027 | $7.0621 | $4.3644 | $29.99 | -0.81% |
Adial Pharmaceuticals Inc Stock (ADIL) Price Forecast for 2028
In 2028, Adial Pharmaceuticals Inc (ADIL) is projected to reach an average price of $8.0437, with a high projection of $11.41 and a low estimate of $4.674. This indicates an +12.97% rise from the last price of $7.12.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $7.9838 | $7.5005 | $7.1813 | +12.13% |
| February, 2028 | $11.17 | $9.0468 | $9.3223 | +56.91% |
| March, 2028 | $11.60 | $11.20 | $11.41 | +62.90% |
| April, 2028 | $11.21 | $11.65 | $10.90 | +57.51% |
| May, 2028 | $11.74 | $11.71 | $11.14 | +64.90% |
| June, 2028 | $8.0096 | $9.0071 | $10.81 | +12.49% |
| July, 2028 | $6.9982 | $6.4379 | $7.1299 | -1.71% |
| August, 2028 | $2.797 | $4.674 | $4.7734 | -60.72% |
| September, 2028 | $6.5405 | $5.615 | $4.793 | -8.14% |
| October, 2028 | $5.5316 | $5.7813 | $5.7758 | -22.31% |
| November, 2028 | $5.3829 | $5.1521 | $5.5727 | -24.40% |
| December, 2028 | $6.369 | $6.0182 | $5.324 | -10.55% |
Adial Pharmaceuticals Inc Stock (ADIL) Price Forecast for 2029
The 2029 price forecast for Adial Pharmaceuticals Inc Stock (ADIL) is $19.85 on average, with a high prediction of $39.48 and a low estimate of $0.2175. This represents an +178.77% increase from the previous price of $7.12.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $2.6003 | $3.7778 | $5.5017 | -63.48% |
| February, 2029 | $6.4364 | $4.9356 | $6.1364 | -9.60% |
| March, 2029 | $6.1774 | $5.4669 | $5.5574 | -13.24% |
| April, 2029 | $5.5785 | $5.5884 | $5.9477 | -21.65% |
| May, 2029 | $5.2398 | $5.4997 | $5.5893 | -26.41% |
| June, 2029 | $4.7307 | $4.7608 | $5.0501 | -33.56% |
| July, 2029 | $4.0219 | $4.1519 | $4.2014 | -43.51% |
| August, 2029 | $3.7931 | $3.8132 | $3.783 | -46.73% |
| September, 2029 | $3.3493 | $3.364 | $3.5335 | -52.96% |
| October, 2029 | $1.5256 | $1.0948 | $1.1156 | -78.57% |
| November, 2029 | $0.5367 | $0.7667 | $1.4761 | -92.46% |
| December, 2029 | $55.73 | $0.2175 | $39.48 | +682.72% |
Adial Pharmaceuticals Inc Stock (ADIL) Price Forecast for 2030
Adial Pharmaceuticals Inc Stock (ADIL) is expected to reach an average price of $54.98 in 2030, with a high forecast of $68.51 and a low forecast of $41.44. This signifies an +672.13% surge from the last price of $7.12.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $63.08 | $60.10 | $58.46 | +785.99% |
| February, 2030 | $61.56 | $66.20 | $64.44 | +764.60% |
| March, 2030 | $65.18 | $63.69 | $61.80 | +815.44% |
| April, 2030 | $68.53 | $71.41 | $66.03 | +862.49% |
| May, 2030 | $68.63 | $68.88 | $68.51 | +863.93% |
| June, 2030 | $66.99 | $69.36 | $66.55 | +840.85% |
| July, 2030 | $67.02 | $66.06 | $64.95 | +841.35% |
| August, 2030 | $42.45 | $51.70 | $65.59 | +496.19% |
| September, 2030 | $42.93 | $41.44 | $40.07 | +502.96% |
| October, 2030 | $61.03 | $49.05 | $52.28 | +757.21% |
| November, 2030 | $65.07 | $65.39 | $60.27 | +813.84% |
| December, 2030 | $64.44 | $64.38 | $61.50 | +805.02% |
0.86%
0.31%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):